Treatment-Related Side Effects Associated with Physical Activity in Breast Cancer Survivors
the Cancer Therapy Advisor take:
Sedentary behavior (SED) was associated with increased levels of treatment-related side effects in breast cancer survivors (BCS), according to an article published online in the journal Psycho-Oncology.
In this study, 195 BCS completed questionnaires regarding demographics, medical variables, and treatment-related side effects, such as pain, fatigue, and depression symptoms.
Accelerometers were used to objectively measure levels of moderate-to-vigorous intensity physical activity (MVPA), light physical activity (PA), and SED.
Results showed that the interaction effect of MVPA by SED was significantly related to pain, fatigue, and depression (P=0.02, P=0.01, P=0.006, respectively).
Furthermore, BCS with lower levels of MVPA and higher levels of SED were more likely to have higher levels of pain, fatigue, and depression (P=0.06, P< 0.001, P=0.08, respectively).
Treatment-related side effects were more prevalent in BCS with higher levels of SED and lower levels of MVPA. However, SED was not significantly associated with fatigue, pain, or depression among survivors with high levels of MVPA.
The study suggests promoting health and physical activity messages as a means of improving management of treatment-related symptoms.
Sedentary behavior was associated with increased levels of treatment-related side effects in breast cancer survivors.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Calcium and Cancer
- Checkpoint Inhibition in Multiple Myeloma After Pembrolizumab-related Clinical Trial Deaths
- Atezolizumab Monotherapy Effective in PD-L1 Non-small Cell Lung Cancer
- Pembrolizumab Prolongs Overall Survival Compared With Ipilimumab in Melanoma
- Cabozantinib Effective as Salvage Therapy in Thyroid Cancer
- Everolimus Maintains Quality of Life in Neuroendocrine Tumors
- High Dose Vitamin B Supplements Should Not Be Taken for Lung Cancer Prevention
- Telomere Length May Predict Renal Cell Carcinoma Risk in Patients with VHL
- Platinum Therapy Should Not Be Delayed in Ovarian Cancer Relapse
- Identifying Frail Patients With Multiple Myeloma Improves Treatment Selection